139 related articles for article (PubMed ID: 15525883)
1. Usefulness of B-type natriuretic peptide (BNP) as a screen for left ventricular abnormalities in diabetes mellitus.
Cosson S
Diabetes Metab; 2004 Sep; 30(4):381-6. PubMed ID: 15525883
[TBL] [Abstract][Full Text] [Related]
2. Utility of B-type natriuretic peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetes.
Epshteyn V; Morrison K; Krishnaswamy P; Kazanegra R; Clopton P; Mudaliar S; Edelman S; Henry R; Maisel A
Diabetes Care; 2003 Jul; 26(7):2081-7. PubMed ID: 12832317
[TBL] [Abstract][Full Text] [Related]
3. Utility of B-type natriuretic peptide as a screen for left ventricular dysfunction in patients with diabetes: response to Epshteyn et al.
Liew D; Schneider H; D'Agostino J; Shaw J; Krum H
Diabetes Care; 2004 Mar; 27(3):848; author reply 848-9. PubMed ID: 14988324
[No Abstract] [Full Text] [Related]
4. Brain natriuretic peptide is related to diastolic dysfunction whereas urinary albumin excretion rate is related to left ventricular mass in asymptomatic type 2 diabetes patients.
Magnusson M; Jovinge S; Shahgaldi K; Israelsson B; Groop L; Melander O
Cardiovasc Diabetol; 2010 Jan; 9():2. PubMed ID: 20078898
[TBL] [Abstract][Full Text] [Related]
5. Early diagnosis of left ventricular diastolic dysfunction in diabetic patients: a possible role for natriuretic peptides.
Romano S; Di Mauro M; Fratini S; Guarracini L; Guarracini F; Poccia G; Penco M
Cardiovasc Diabetol; 2010 Dec; 9():89. PubMed ID: 21162718
[TBL] [Abstract][Full Text] [Related]
6. Use of B-type natriuretic peptide as a screening tool for left ventricular diastolic dysfunction in rheumatoid arthritis patients without clinical cardiovascular disease.
Crowson CS; Myasoedova E; Davis JM; Roger VL; Karon BL; Borgeson D; Rodeheffer RJ; Therneau TM; Gabriel SE
Arthritis Care Res (Hoboken); 2011 May; 63(5):729-34. PubMed ID: 21225672
[TBL] [Abstract][Full Text] [Related]
7. A preliminary evaluation of plasma b-type natriuretic peptide as a screening test for left ventricular diastolic dysfunction in non-cardiac intensive care.
Sturgess DJ; Parmar D; Dulhunty JM; Hedge R; Jarrett P; Udy A
Anaesth Intensive Care; 2013 Sep; 41(5):591-5. PubMed ID: 23977909
[TBL] [Abstract][Full Text] [Related]
8. Changes in B-type natriuretic peptide levels in hemodialysis and the effect of depressed left ventricular function.
Safley DM; Awad A; Sullivan RA; Sandberg KR; Mourad I; Boulware M; Merhi W; McCullough PA
Adv Chronic Kidney Dis; 2005 Jan; 12(1):117-24. PubMed ID: 15719344
[TBL] [Abstract][Full Text] [Related]
9. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study.
Vasan RS; Benjamin EJ; Larson MG; Leip EP; Wang TJ; Wilson PW; Levy D
JAMA; 2002 Sep; 288(10):1252-9. PubMed ID: 12215132
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of an elevated B-type natriuretic peptide to predict allograft failure, cardiac allograft vasculopathy, and survival after heart transplantation.
Mehra MR; Uber PA; Potluri S; Ventura HO; Scott RL; Park MH
Am J Cardiol; 2004 Aug; 94(4):454-8. PubMed ID: 15325928
[TBL] [Abstract][Full Text] [Related]
11. B-Type Natriuretic Peptide and Ventricular Dysfunction in the Prediction of Cardiovascular Events and Death in Hypertension.
Gallagher J; Watson C; Zhou S; Ryan F; Ledwidge M; McDonald K
Am J Hypertens; 2018 Jan; 31(2):228-234. PubMed ID: 29036547
[TBL] [Abstract][Full Text] [Related]
12. Performance of phonoelectrocardiographic left ventricular systolic time intervals and B-type natriuretic peptide levels in the diagnosis of left ventricular dysfunction.
Moyers B; Shapiro M; Marcus GM; Gerber IL; McKeown BH; Vessey JC; Jordan MV; Huddleston M; Foster E; Chatterjee K; Michaels AD
Ann Noninvasive Electrocardiol; 2007 Apr; 12(2):89-97. PubMed ID: 17593176
[TBL] [Abstract][Full Text] [Related]
13. [Clinical applications of brain natriuretic peptide testing].
Scardovi AB; ; ; ; ;
Ital Heart J Suppl; 2004 May; 5(5):343-56. PubMed ID: 15182061
[TBL] [Abstract][Full Text] [Related]
14. The BNP assay does not identify mild left ventricular diastolic dysfunction in asymptomatic diabetic patients.
Valle R; Bagolin E; Canali C; Giovinazzo P; Barro S; Aspromonte N; Carbonieri E; Milani L
Eur J Echocardiogr; 2006 Jan; 7(1):40-4. PubMed ID: 15886060
[TBL] [Abstract][Full Text] [Related]
15. Systolic and diastolic heart failure are associated with different plasma levels of B-type natriuretic peptide.
Wei T; Zeng C; Chen L; Chen Q; Zhao R; Lu G; Lu C; Wang L
Int J Clin Pract; 2005 Aug; 59(8):891-4. PubMed ID: 16033608
[TBL] [Abstract][Full Text] [Related]
16. Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction.
Hammerer-Lercher A; Neubauer E; Müller S; Pachinger O; Puschendorf B; Mair J
Clin Chim Acta; 2001 Aug; 310(2):193-7. PubMed ID: 11498085
[TBL] [Abstract][Full Text] [Related]
17. Retrospective analysis of the cost-effectiveness of using plasma brain natriuretic peptide in screening for left ventricular systolic dysfunction in the general population.
Nielsen OW; McDonagh TA; Robb SD; Dargie HJ
J Am Coll Cardiol; 2003 Jan; 41(1):113-20. PubMed ID: 12570953
[TBL] [Abstract][Full Text] [Related]
18. Serum N-terminal-pro-brain natriuretic peptide (NT-pro-BNP) and homocysteine levels in type 2 diabetic patients with asymptomatic left ventricular diastolic dysfunction.
Görmüş U; Ozmen D; Ozmen B; Parildar Z; Ozdoğan O; Mutaf I; Bayindir O
Diabetes Res Clin Pract; 2010 Jan; 87(1):51-6. PubMed ID: 19932518
[TBL] [Abstract][Full Text] [Related]
19. Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction.
Nousiainen T; Vanninen E; Jantunen E; Puustinen J; Remes J; Rantala A; Vuolteenaho O; Hartikainen J
J Intern Med; 2002 Mar; 251(3):228-34. PubMed ID: 11886482
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic utility of brain-natriuretic peptide for left ventricular diastolic dysfunction in asymptomatic type 2 diabetic patients.
Shimabukuro M; Higa N; Oshiro Y; Asahi T; Takasu N
Diabetes Obes Metab; 2007 May; 9(3):323-9. PubMed ID: 17391158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
